TCT 2013 Events Announcement
Tryton Medical Introduces Physician Education Program
Tryton Medical Introduces Physician Education Program
Tryton Medical Announces Successful Live Case Transmission With New Tryton Side Branch SHORT Stent
Tryton Medical Announces Successful Live Case Transmission With New Tryton Side Branch SHORT Stent
Tryton Medical Announces Nordic-Baltic Dedicated Bifurcation Trial Studying the Tryton Side Branch Stent
Tryton Medical Announces Nordic-Baltic Dedicated Bifurcation Trial Studying the Tryton Side Branch Stent
Tryton Medical Announces Events at EuroPCR 2013 in Paris
Tryton Medical Announces Events at EuroPCR 2013 in Paris
Tryton Medical Completes $24 Million Equity Financing with Strong Participation from All Current Investors
Tryton Medical Completes $24 Million Equity Financing
Tryton Pivotal IDE study complete
Tryton Pivotal IDE study complete FINAL[3][1]
Tryton Presents Positive Data from More Than 900 Patients at TCT 2012 Conference in Miami
Oct 29, 2012: Tryton Presents Positive Data from More Than 900 Patients at TCT 2012 Conference in Miami Growing Body of Data Positions Tryton Stent As Potential Alternative to Provisional Stenting Download PDF
Tryton Announces Positive Clinical Data from More Than 900 Patients Treated with Its Bifurcation Stent System at EuroPCR 2012
May 23, 2012: Tryton Announces Positive Clinical Data from More Than 900 Patients Treated with Its Bifurcation Stent System at EuroPCR 2012 Pooled Analysis of Results Examines Evidence from Eight Clinical Studies Download PDF